DEMONSTRATION WEBSITE: This site is for demonstration, web development, and research purposes only. This site is under development and in no way, shape, or form is an offer, solicitation, or representation of any service. This is a demo website.

Comprehensive technical and business documentation detailing our AI-powered healthcare platform, market opportunity, and investment structure.
Global digital health market by 2031
Full federal regulatory compliance
Phase 1 deployment target
Our white paper provides in-depth analysis across eight key areas, totaling 85 pages of technical, clinical, and financial documentation.
Overview of Royal Ponciana MedTech's mission, market opportunity, and strategic approach to AI-powered healthcare delivery.
Comprehensive analysis of the $266.5B digital health market, nursing shortage crisis, and federal healthcare spending trends.
Detailed technical specifications of our AI virtual nursing platform, edge computing infrastructure, and blockchain security layer.
Evidence-based research on AI-assisted nursing outcomes, patient safety improvements, and quality of care metrics.
HIPAA, FDA, and federal healthcare compliance framework, including stem cell therapy regulations and medical device certifications.
Revenue models, market penetration strategy, and projected returns for token holders with quarterly 8% yield structure.
Solana-based LXUSD stablecoin mechanics, conversion to LP units, and blockchain-secured dividend distribution.
Comprehensive disclosure of medical, regulatory, market, and technology risks associated with the investment.
Access our complete white paper and supporting documentation. All documents are available for accredited investors and qualified partners.
Complete technical and business documentation (PDF, 85 pages)
File size: 12.4 MB
High-level overview for investors and partners (PDF, 8 pages)
File size: 2.1 MB
Detailed architecture and API documentation (PDF, 42 pages)
File size: 8.7 MB
Revenue projections and token economics (Excel)
File size: 1.8 MB
Accredited Investor Notice: Some documents contain forward-looking statements and financial projections intended only for accredited investors as defined by SEC regulations. By downloading, you certify that you meet these requirements.
Our team is available to discuss technical details, clinical applications, and investment opportunities with qualified partners and investors.